Conversely, IL-33 attenuated tumour growth and metastasis in the B16 melanoma, 3LL and 4T1 mammary tumour models by increasing the cytotoxicity and tumour infiltration of CD8+ T cells and NK cells27, 28. Here, IL33 is linked to neoplasm.